Dimitrios Zouzoulas1,2, Dimitrios Tsolakidis3, Georgios Gitas4, Menelaos Zafrakas5, Dimitrios G Goulis3, George Douganiotis6, Georgios Sympilidis7, Grigorios Grimbizis3. 1. Surgical-Oncologic Breast Cancer Department, "Theagenio" Anticancer Hospital, Thessaloniki, Greece. dzouzoulas@hotmail.gr. 2. 1st Department of Obstetrics - Gynecology Clinic, AUTh, "Papageorgiou" Hospital, Thessaloniki, Greece. dzouzoulas@hotmail.gr. 3. 1st Department of Obstetrics - Gynecology Clinic, AUTh, "Papageorgiou" Hospital, Thessaloniki, Greece. 4. Department of Gynaecology and Obstetrics, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany. 5. ATEITh, Thessaloniki, Greece. 6. 3rd Department of Clinical Oncology, "Thegeneio" Anticancer Hospital, Thessaloniki, Greece. 7. Surgical-Oncologic Breast Cancer Department, "Theagenio" Anticancer Hospital, Thessaloniki, Greece.
Abstract
PURPOSE: Women ≤ 35 years old with breast cancer constitute a special group. Considering the impact of the disease and its prognosis, these patients face some specific problems that are not present in older women. What are the prognostic features of the survival rate in very young women with breast cancer? METHODS: Retrospective analysis of very young women with breast cancer from the Surgical-Oncologic Breast Cancer Department at "Theagenio" Anticancer Hospital, 2003-2016. Patient and tumor characteristics, treatment options and follow-up information were collected. Univariate-multivariate analyses were conducted and survival rates were calculated. RESULTS: The median age was 34 years old. 53 patients (41%) had T1, 36 (28%) had T2, 7 (5.4%) had T3 and 33 (25.6%) had T4 stage tumors. Most women, 114 (88.4%), had ductal carcinoma in their histology. Furthermore, positive axillary lymph nodes were present in 62 women (48%). In the immunochemistry report, 91 patients (70.5%) were hormone receptor positive, HER2 was overexpressed in 32 patients (24.8%) and 27 patients presented with triple-negative subtype. Out of 65 patients tested for Ki-67, 51 (78.5%), had a high expression (cut-off value of 20%). After adjusting for all possible factors, the risk of recurrence and death was six times higher in the positive lymph node group, (p < 0.001). The median disease-free and overall survival was 133 and > 173 months, respectively. CONCLUSION: Breast cancer in very young women appears with large size and high-grade tumors, high incidence of infiltrated axillary lymph nodes, high Ki-67 expression and intrinsic subtypes with poor prognosis. As a result, these women need to be treated by a multidisciplinary team.
PURPOSE:Women ≤ 35 years old with breast cancer constitute a special group. Considering the impact of the disease and its prognosis, these patients face some specific problems that are not present in older women. What are the prognostic features of the survival rate in very young women with breast cancer? METHODS: Retrospective analysis of very young women with breast cancer from the Surgical-Oncologic Breast Cancer Department at "Theagenio" Anticancer Hospital, 2003-2016. Patient and tumor characteristics, treatment options and follow-up information were collected. Univariate-multivariate analyses were conducted and survival rates were calculated. RESULTS: The median age was 34 years old. 53 patients (41%) had T1, 36 (28%) had T2, 7 (5.4%) had T3 and 33 (25.6%) had T4 stage tumors. Most women, 114 (88.4%), had ductal carcinoma in their histology. Furthermore, positive axillary lymph nodes were present in 62 women (48%). In the immunochemistry report, 91 patients (70.5%) were hormone receptor positive, HER2 was overexpressed in 32 patients (24.8%) and 27 patients presented with triple-negative subtype. Out of 65 patients tested for Ki-67, 51 (78.5%), had a high expression (cut-off value of 20%). After adjusting for all possible factors, the risk of recurrence and death was six times higher in the positive lymph node group, (p < 0.001). The median disease-free and overall survival was 133 and > 173 months, respectively. CONCLUSION:Breast cancer in very young women appears with large size and high-grade tumors, high incidence of infiltrated axillary lymph nodes, high Ki-67 expression and intrinsic subtypes with poor prognosis. As a result, these women need to be treated by a multidisciplinary team.
Entities:
Keywords:
Breast cancer; Prognostic features; Survival rates; Very young women
Authors: Michael C Hartley; Brian P McKinley; Emily A Rogers; Corey A Kalbaugh; H S Messich; Dawn W Blackhurst; Jonathan S Lokey; Steven D Trocha Journal: Am Surg Date: 2006-12 Impact factor: 0.688
Authors: Carey K Anders; David S Hsu; Gloria Broadwater; Chaitanya R Acharya; John A Foekens; Yi Zhang; Yixin Wang; P Kelly Marcom; Jeffrey R Marks; Phillip G Febbo; Joseph R Nevins; Anil Potti; Kimberly L Blackwell Journal: J Clin Oncol Date: 2008-07-10 Impact factor: 44.544
Authors: S Paluch-Shimon; F Cardoso; A H Partridge; O Abulkhair; H A Azim; G Bianchi-Micheli; M-J Cardoso; G Curigliano; K A Gelmon; N Harbeck; J Merschdorf; P Poortmans; G Pruneri; E Senkus; T Spanic; V Stearns; Y Wengström; F Peccatori; O Pagani Journal: Ann Oncol Date: 2020-03-19 Impact factor: 32.976
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Hassan K Abdulwassi; Ibrahim T Amer; Ahmad H Alhibshi; Abdullah A Alnajjar; Abdulrahman K Bahatheq; Nora H Trabulsi; Mohammed O Nassif Journal: Saudi Med J Date: 2020-04 Impact factor: 1.484